The interaction with ERM proteins is critical for podoplanin-mediated rearrangement of the actin cytoskeleton and modulation of small Rho GTPases, and is involved in promoting epithelial–mesenchymal transitions (EMTs) during embryonic development and cancer [9,10,37]. The gene discussed is PDPN; the disease is cancer.